PD-1 inhibitor in combination with fruquintinib therapy for initial unresectable colorectal cancer: A case report.

Zhang, Hong-Qiang; Huang, Chang-Zhi; Wu, Jing-Yu; Wang, Zhen-Ling; Shao, Yu; Fu, Zan.

Afiliação

Zhang HQ; Department of General Surgery, The First Affiliated Hospital of Nanjing Medical University, Nanjing 210029, Jiangsu Province, China.
Huang CZ; Department of General Surgery, The First Affiliated Hospital of Nanjing Medical University, Nanjing 210029, Jiangsu Province, China.
Wu JY; Department of General Surgery, The First Affiliated Hospital of Nanjing Medical University, Nanjing 210029, Jiangsu Province, China.
Wang ZL; Department of General Surgery, The First Affiliated Hospital of Nanjing Medical University, Nanjing 210029, Jiangsu Province, China.
Shao Y; Department of General Surgery, The First Affiliated Hospital of Nanjing Medical University, Nanjing 210029, Jiangsu Province, China.
Fu Z; Department of General Surgery, The First Affiliated Hospital of Nanjing Medical University, Nanjing 210029, Jiangsu Province, China. fuzan1971@njmu.edu.cn.

World J Clin Cases ; 10(14): 4669-4675, 2022 May 16.

Article em En | MEDLINE | ID: mdl-35663084